Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CNK Stock Summary
Top 10 Correlated ETFs
CNK
In the News
VCR: Consumer Discretionary Sector Dashboard For March
VCR: Consumer Discretionary Sector Dashboard For March
Cinemark to Participate in Upcoming Institutional Investor Conference
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibitors in the world, today announced participation at the following institutional investor conference: Tuesday, March 19: 36th Annual Roth MKM Investor Conference in Dana Point, CA Melissa Thomas, CFO, and Chanda Brashears, SVP Investor Relations 1:1 investor meetings Fireside chat at 10:30 am PT https://wsw.com/webcast/roth48/cnk/1672060 About Cinemark Holdings, Inc.: Cinemark Holdings, In.
Don't Bury Movie Theater Stocks
People have been staying away from movie theaters in 2024. A weekend earlier in the month drew the smallest audiences in nearly three years.
Cinemark (CNK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Cinemark (CNK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cinemark Holdings (CNK) Reports Q4 Loss, Tops Revenue Estimates
Cinemark Holdings (CNK) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.82 per share a year ago.
AMC's stock has tumbled. CEO Adam Aron says he'll ‘have much to say' on the company's Q4 earnings call.
Shares of AMC Entertainment Holdings Inc. have hit a series of record lows recently. AMC CEO Adam Aron says that he will “have much to say” about “what is going on” when the company reports its fourth-quarter results on Feb. 28.
Cinemark's stock slides 1.8% after company posts wider-than-expected Q4 loss
Cinemark Holdings Inc.'s stock CNK, +4.88% fell 1.8% early Friday, after the cinema operator's fourth-quarter loss was wider than expected. Plano, Texas-based Cinemark posted a net loss of $18 million, or 15 cents a share, for the quarter, narrower than the loss of $99.3 million, or 82 cents a share, posted in the year-earlier period.
Cinemark (CNK) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cinemark (CNK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Cinemark to Participate in Upcoming Institutional Investor Conferences
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibitors in the world, today announced participation at the following institutional investor conferences: Tuesday, February 27: J.P. Morgan High Yield & Leveraged Finance Conference in Miami, FL Melissa Thomas, CFO, and Chanda Brashears, SVP Investor Relations 1:1 investor meetings Fireside chat at 10:15 am ET https://jpmorgan.metameetings.net/events/highyield24/sessions/50389-cinemark-ho.
Cinemark Holdings (CNK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cinemark (CNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNK Financial details
CNK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 28.23 | 5.88 | 12.88 | 20.79 | 20.18 | |
Net income per share | 1.65 | -5.3 | -3.6 | -2.27 | 1.24 | |
Operating cash flow per share | 4.83 | -2.83 | 1.42 | 1.15 | 2.92 | |
Free cash flow per share | 2.22 | -3.55 | 0.6 | 0.21 | 1.94 | |
Cash per share | 4.2 | 5.62 | 6.03 | 5.71 | 5.59 | |
Book value per share | 12.45 | 6.75 | 2.75 | 0.93 | 2.04 | |
Tangible book value per share | -1.35 | -6.59 | -10.45 | -12.16 | -8.13 | |
Share holders equity per share | 12.45 | 6.75 | 2.75 | 0.93 | 2.04 | |
Interest debt per share | 30.13 | 35.01 | 35.12 | 33.5 | 18.41 | |
Market cap | 3.94B | 2.03B | 1.89B | 1.02B | 2.14B | |
Enterprise value | 6.82B | 5.31B | 5.13B | 4.13B | 4.85B | |
P/E ratio | 20.57 | -3.29 | -4.48 | -3.82 | 11.38 | |
Price to sales ratio | 1.2 | 2.96 | 1.25 | 0.42 | 0.7 | |
POCF ratio | 7.01 | -6.15 | 11.37 | 7.52 | 4.82 | |
PFCF ratio | 15.24 | -4.91 | 26.74 | 40.42 | 7.26 | |
P/B Ratio | 2.72 | 2.58 | 5.85 | 9.28 | 6.91 | |
PTB ratio | 2.72 | 2.58 | 5.85 | 9.28 | 6.91 | |
EV to sales | 2.08 | 7.73 | 3.39 | 1.68 | 1.58 | |
Enterprise value over EBITDA | 9.27 | -15.38 | 145.15 | 12.5 | 8.34 | |
EV to operating cash flow | 12.14 | -16.08 | 30.85 | 30.34 | 10.91 | |
EV to free cash flow | 26.41 | -12.82 | 72.55 | 163.08 | 16.44 | |
Earnings yield | 0.05 | -0.3 | -0.22 | -0.26 | 0.09 | |
Free cash flow yield | 0.07 | -0.2 | 0.04 | 0.02 | 0.14 | |
Debt to equity | 2.33 | 4.99 | 12.22 | 34.28 | 8.48 | |
Debt to assets | 0.58 | 0.71 | 0.75 | 0.78 | 0.54 | |
Net debt to EBITDA | 3.92 | -9.49 | 91.65 | 9.4 | 4.65 | |
Current ratio | 0.9 | 1.47 | 1.14 | 1.22 | 1.45 | |
Interest coverage | 3.69 | -3.85 | -1.33 | 0.51 | 2.15 | |
Income quality | 2.9 | 0.53 | -0.39 | -0.51 | 2.4 | |
Dividend Yield | 0.04 | 0.02 | 0 | 0 | 0 | |
Payout ratio | 0.83 | -0.07 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.43 | 1.14 | 0.63 | 0.35 | 0.3 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.28 | 0.28 | 0.3 | 0.32 | 0.32 | |
Capex to operating cash flow | -0.54 | 0.25 | -0.57 | -0.81 | -0.34 | |
Capex to revenue | -0.09 | -0.12 | -0.06 | -0.05 | -0.05 | |
Capex to depreciation | -1.16 | -0.32 | -0.36 | -0.46 | -0.71 | |
Stock based compensation to revenue | 0 | 0.03 | 0.02 | 0.01 | 0.01 | |
Graham number | 21.47 | 28.37 | 14.94 | 6.9 | 7.54 | |
ROIC | 0.05 | -0.06 | -0.04 | 0.02 | 0.08 | |
Return on tangible assets | 0.05 | -0.15 | -0.12 | -0.08 | 0.06 | |
Graham Net | -32.8 | -33.94 | -34.92 | -33.24 | -23.38 | |
Working capital | -73.81M | 286.31M | 105.33M | 155.1M | 329.7M | |
Tangible asset value | -156.82M | -769.07M | -1.23B | -1.44B | -1.24B | |
Net current asset value | -3.74B | -3.87B | -4.02B | -3.83B | -3.46B | |
Invested capital | 2.33 | 4.99 | 12.22 | 34.28 | 8.48 | |
Average receivables | 93.09M | 139.11M | 152.94M | 115.09M | 125.9M | |
Average payables | 98.12M | 81.13M | 73.32M | 74.1M | 62.75M | |
Average inventory | 20.5M | 17.14M | 14.02M | 19.58M | 23.5M | |
Days sales outstanding | 9.76 | 101.27 | 27.9 | 17.06 | 16.32 | |
Days payables outstanding | 27.63 | 109.51 | 54.09 | 30.16 | 7.79 | |
Days of inventory on hand | 6.54 | 19.52 | 11 | 9.9 | 3.41 | |
Receivables turnover | 37.39 | 3.6 | 13.08 | 21.4 | 22.37 | |
Payables turnover | 13.21 | 3.33 | 6.75 | 12.1 | 46.83 | |
Inventory turnover | 55.81 | 18.7 | 33.19 | 36.86 | 107.13 | |
ROE | 0.13 | -0.78 | -1.31 | -2.43 | 0.61 | |
Capex per share | -2.61 | -0.72 | -0.81 | -0.94 | -0.98 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.06 | 5.14 | 6.46 | 6.04 | 5.36 | |
Net income per share | -0.83 | -0.02 | 0.82 | 0.62 | -0.15 | |
Operating cash flow per share | 0.91 | 0.07 | 1.7 | 0.55 | 0.91 | |
Free cash flow per share | 0.53 | -0.15 | 1.51 | 0.31 | 0.41 | |
Cash per share | 5.69 | 5.57 | 5.29 | 5.43 | 7.12 | |
Book value per share | 0.93 | 1.04 | 1.68 | 2.25 | 2.6 | |
Tangible book value per share | -12.12 | -12.07 | -8.94 | -8.4 | -10.36 | |
Share holders equity per share | 0.93 | 1.04 | 1.68 | 2.25 | 2.6 | |
Interest debt per share | 32.27 | 31.82 | 25.16 | 25.1 | 22.4 | |
Market cap | 1.03B | 1.76B | 2.41B | 2.66B | 1.68B | |
Enterprise value | 4.13B | 4.84B | 5.28B | 5.44B | 4.38B | |
P/E ratio | -2.6 | -175.71 | 5.06 | 7.36 | -23.72 | |
Price to sales ratio | 1.71 | 2.88 | 2.56 | 3.04 | 2.63 | |
POCF ratio | 9.48 | 222.41 | 9.71 | 33.3 | 15.48 | |
PFCF ratio | 16.31 | -95.49 | 10.96 | 59.44 | 34.49 | |
P/B Ratio | 9.31 | 14.19 | 9.84 | 8.17 | 5.42 | |
PTB ratio | 9.31 | 14.19 | 9.84 | 8.17 | 5.42 | |
EV to sales | 6.89 | 7.93 | 5.6 | 6.22 | 6.86 | |
Enterprise value over EBITDA | 56.11 | 51.43 | 21.78 | 25.86 | 57.9 | |
EV to operating cash flow | 38.13 | 613.26 | 21.28 | 68.19 | 40.4 | |
EV to free cash flow | 65.65 | -263.3 | 24.02 | 121.74 | 90 | |
Earnings yield | -0.1 | 0 | 0.05 | 0.03 | -0.01 | |
Free cash flow yield | 0.06 | -0.01 | 0.09 | 0.02 | 0.03 | |
Debt to equity | 34.28 | 30.19 | 14.83 | 11.04 | 8.48 | |
Debt to assets | 0.78 | 0.79 | 0.75 | 0.75 | 0.54 | |
Net debt to EBITDA | 42.16 | 32.78 | 11.85 | 13.24 | 35.71 | |
Current ratio | 1.22 | 1.12 | 1.31 | 1.55 | 1.45 | |
Interest coverage | 0.35 | 0.92 | 3.93 | 3.34 | 0.59 | |
Income quality | -1.1 | -3.16 | 1.9 | 0.98 | -6.13 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | -0.15 | 0.52 | 0.39 | 0.42 | -0.19 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.32 | 0.33 | 0.32 | 0.32 | 0.32 | |
Capex to operating cash flow | -0.42 | -3.33 | -0.11 | -0.44 | -0.55 | |
Capex to revenue | -0.08 | -0.04 | -0.03 | -0.04 | -0.09 | |
Capex to depreciation | -0.79 | -0.48 | -0.54 | -0.68 | -1.2 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 4.18 | 0.7 | 5.55 | 5.61 | 2.95 | |
ROIC | 0 | 0 | 0.03 | 0.02 | 0.01 | |
Return on tangible assets | -0.03 | 0 | 0.04 | 0.03 | -0.01 | |
Graham Net | -33.13 | -32.31 | -25.4 | -24.77 | -29.82 | |
Working capital | 155.1M | 85.7M | 230.7M | 359.1M | 329.7M | |
Tangible asset value | -1.44B | -1.43B | -1.31B | -1.22B | -1.24B | |
Net current asset value | -3.83B | -3.76B | -3.62B | -3.47B | -3.46B | |
Invested capital | 34.28 | 30.19 | 14.83 | 11.04 | 8.48 | |
Average receivables | 106.25M | 109M | 117.25M | 125.7M | 128.65M | |
Average payables | 221.85M | 232.85M | 447.1M | 456.8M | 233.1M | |
Average inventory | 21.65M | 22.8M | 24.7M | 27.2M | 25.1M | |
Days sales outstanding | 17.21 | 15.22 | 12.53 | 12.37 | 19.31 | |
Days payables outstanding | 30.39 | 168.4 | 130.47 | 119.41 | 8.58 | |
Days of inventory on hand | 9.98 | 9.37 | 7.17 | 7.78 | 3.75 | |
Receivables turnover | 5.23 | 5.91 | 7.18 | 7.28 | 4.66 | |
Payables turnover | 2.96 | 0.53 | 0.69 | 0.75 | 10.49 | |
Inventory turnover | 9.02 | 9.6 | 12.56 | 11.57 | 23.99 | |
ROE | -0.9 | -0.02 | 0.49 | 0.28 | -0.06 | |
Capex per share | -0.38 | -0.22 | -0.19 | -0.24 | -0.5 |
CNK Frequently Asked Questions
What is Cinemark Holdings, Inc. stock symbol ?
Cinemark Holdings, Inc. is a US stock , located in Plano of Tx and trading under the symbol CNK
Is Cinemark Holdings, Inc. buy or a sell ?
6 stock analysts have 6 predictions with a medium analyst target price of $22.17. The lowest prediction is $14 and the highest is $32
What is CNK stock prediction ?
What is Cinemark Holdings, Inc. stock quote today ?
Cinemark Holdings, Inc. stock price is $17.95 today.
Is Cinemark Holdings, Inc. stock public?
Yes, Cinemark Holdings, Inc. is a publicly traded company.